Výsledky vyhledávání

Assessement of Awareness of, Concerns and Attitudes Towards HIV-Related Court-Case Sentences in France in a Representative Sample of People Living with HIV (ANRS VESPA2 Survey)

Autor: Marie Suzan-Monti, Bruno Spire, Antoine Vilotitch, Rosemary Dray-Spira, Patrick Yeni, Michel Celse, Baptiste Demoulin

Publikováno v: AIDS and Behavior
AIDS and Behavior, Springer Verlag, 2018, 22 (10), pp.3264-3272. ⟨10.1007/s10461-018-2077-6⟩

International audience; Some of the 12 criminal trials and sentences in France for HIV transmission in 1998-2011 attracted substantial public attention , with a possible negative impact on people living with HIV (PLWH) through reinforced stigma and d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2637422188549dc6dffd9a3d947bc81
https://doi.org/10.1007/s10461-018-2077-6

Zobrazit plný text záznamu

Akademický článek

Secondary healthcare resource utilization and related costs associated with influenza-related hospital admissions in adult patients, England 2016 - 2020.

Autor: de Courville C; Health Economics & Value Assessment, Sanofi, Lyon, France., Bricout H; Medical Evidence Generation, Sanofi, Lyon, France., Alvarez FP; Health Economics & Value Assessment, Sanofi, Lyon, France., Clouting J; Patient and Market Access, IQVIA, London, UK., Patel S; EMEA Real World Methods & Evidence Generation, IQVIA, London, UK., Mohamed H; EMEA Real World Methods & Evidence Generation, IQVIA, London, UK., Giblin S; Patient and Market Access, IQVIA, London, UK., Coles B; EMEA Real World Methods & Evidence Generation, IQVIA, London, UK.

Publikováno v: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2024 Nov 14, pp. 1-13. Date of Electronic Publication: 2024 Nov 14.

Zobrazit plný text záznamu

Akademický článek

Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population.

Autor: Alvarez FP; Sanofi, Lyon, France., Allard L; Sanofi, Lyon, France., Bianic F; Syneos Health, Paris, France., Bricout H; Sanofi, Lyon, France., Crépey P; EHESP, Université de Rennes, REPERES, Rennes, France., Gaillat J; Centre Hospitalier Annecy-Genevois, Metz-Tessy, France., Gavazzi G; CHU Grenoble-Alpes, Grenoble, France., Mosnier A; Open Rome & Réseau des GROG, Paris, France., Launay O; Faculté de Médecine Paris Descartes, Université de Paris, Paris, France., Levant MC; Sanofi, Lyon, France., Proshenska D; Syneos Health, Paris, France., de Courville C; Sanofi, Lyon, France.

Publikováno v: Journal of medical economics [J Med Econ] 2024 Jan-Dec; Vol. 27 (1), pp. 1300-1307. Date of Electronic Publication: 2024 Oct 01.

Zobrazit plný text záznamu

Akademický článek

Cost-effectiveness for high dose quadrivalent versus the adjuvanted quadrivalent influenza vaccine in the Italian older adult population.

Autor: Rumi F; Alta Scuola di Economia e Management dei Sistemi Sanitari, Università Cattolica del Sacro Cuore, Rome, Italy., Basile M; Alta Scuola di Economia e Management dei Sistemi Sanitari, Università Cattolica del Sacro Cuore, Rome, Italy., Cicchetti A; Alta Scuola di Economia e Management dei Sistemi Sanitari, Università Cattolica del Sacro Cuore, Rome, Italy., Alvarez FP; Sanofi, Lyon, France., Azzi MV; Sanofi, Milan, Italy., Muzii B; Sanofi, Milan, Italy.

Publikováno v: Frontiers in public health [Front Public Health] 2023 Nov 13; Vol. 11, pp. 1200116. Date of Electronic Publication: 2023 Nov 13 (Print Publication: 2023).

Zobrazit plný text záznamu

Akademický článek

Estimated health and economic impact of using high-dose influenza vaccine on respiratory and circulatory plus respiratory hospitalizations of older adults in Australia.

Autor: Raina MacIntyre C; Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Kevin Yin J; Medical Department, Greater China, Sanofi Vaccines, Beijing, China.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Felter C; Medical Team, Sanofi, Sydney, NSW, Australia., Menzies RI; Sanofi Vaccines, Australia & New Zealand., Thommes E; New Products and Innovation, Sanofi, Toronto, Ontario, Canada.; Department of Mathematics and Statistics, University of Guelph, Guelph, ON, Canada., Largeron N; Health Economics, Sanofi, Lyon, France., Moa AM; Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Trent M; Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Costantino V; Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Choi S; Market Access, Sanofi, Sydney, NSW, Australia., Alvarez FP; Health Economics, Sanofi, Lyon, France.

Publikováno v: Vaccine: X [Vaccine X] 2023 Aug 04; Vol. 15, pp. 100365. Date of Electronic Publication: 2023 Aug 04 (Print Publication: 2023).

Zobrazit plný text záznamu

Corrigendum to "Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35 months: Analysis of data from a phase III trial in the northern and southern Hemispheres" [Vaccine 37(13) (2019) 1885-1888].

Autor: Pepin S; Sanofi Pasteur, 1541 Avenue Marcel Merieux, 69820 Marcy-l'Étoile, France. Electronic address: stephanie.pepin@sanofi.com., Samson SI; Sanofi Pasteur, 1 Discovery Dr, Swiftwater, PA 18370, USA. Electronic address: Sandrine.Samson@sanofi.com., Alvarez FP; Sanofi Pasteur, 14 Espace Henry Vallée, 69007 Lyon, France. Electronic address: Fabian.Alvarez@sanofi.com., Dupuy M; Sanofi Pasteur, 1541 Avenue Marcel Merieux, 69820 Marcy-l'Étoile, France. Electronic address: Martin.Dupuy@sanofi.com., Gresset-Bourgeois V; Sanofi Pasteur, 14 Espace Henry Vallée, 69007 Lyon, France. Electronic address: Viviane.Gresset-Bourgeois@sanofi.com., De Bruijn I; Sanofi Pasteur, 1541 Avenue Marcel Merieux, 69820 Marcy-l'Étoile, France. Electronic address: Iris.DeBruijn@sanofi.com.

Publikováno v: Vaccine [Vaccine] 2023 Jan 09; Vol. 41 (2), pp. 621. Date of Electronic Publication: 2022 Dec 09.

Zobrazit plný text záznamu

Akademický článek

Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal.

Autor: Alvarez FP; Sanofi, Lyon, France., Chevalier P; IQVIA, Zaventem, Belgium., Borms M; IQVIA, Zaventem, Belgium., Bricout H; Sanofi, Lyon, France., Marques C; Sanofi, Porto Salvo, Portugal., Soininen A; Sanofi, Espoo, Finland., Sainio T; Medaffcon Oy, Espoo, Finland., Petit C; Sanofi, Diegem, Belgium., de Courville C; Sanofi, Lyon, France.

Publikováno v: Journal of medical economics [J Med Econ] 2023 Jan-Dec; Vol. 26 (1), pp. 710-719.

Zobrazit plný text záznamu

Akademický článek

Reply to letter by Hadigal et al. regarding the cost-effectiveness of high dose quadrivalent vaccine in three European countries.

Autor: Alvarez FP; Sanofi, Lyon, France., Bricout H; Sanofi, Lyon, France., Marques C; Sanofi, Porto Salvo, Portugal., Soininen A; Sanofi, Espoo, Finland., Sainio T; Medaffcon Oy, Espoo, Finland., Petit C; Diegem, Belgium Sanofi., de Courville C; Sanofi, Lyon, France., Chevalierf P; IQVIA - Real World Evidence Solutions & HEOR Corporate Village, Zaventem, Belgium.

Publikováno v: Journal of medical economics [J Med Econ] 2023 Jan-Dec; Vol. 26 (1), pp. 1167-1168. Date of Electronic Publication: 2023 Jul 17.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání